TABLE 3.
Compound # | RT (min.) | Base peak (m/z) | Fragmentation (m/z) | EC50 (SEM) nM |
---|---|---|---|---|
18 | 12.79 | 293 | 43, 180, 223, 293 | >2000 |
7 | 14.41 | 287 | 71, 146, 189, 287 | 390 (96) |
5 | 13.92 | 285 | 69, 146, 189, 285 | 600 (190) |
29 | 12.88 | 279 | 57, 180, 223, 279 | >1000 |
15 | 11.32 | 277 | 43, 164, 207, 277 | 42 (13) |
16 | 11.06 | 277 | 43, 164, 207, 277 | >500 |
21 | 11.82 | 277 | 43, 164, 207, 277 | 60 (15) |
17 | 11.85 | 273 | 105, 160, 203, 273 | >1000 |
3 | 12.84 | 271 | 69, 160, 203, 271 | >1000 |
4 | 13.24 | 271 | 55, 146, 189, 271 | 160 (30) |
23 | 11.57 | 263 | 57, 164, 207, 263 | 15 (4) |
24 | 11.39 | 263 | 57, 164, 207, 263 | 164 (24) |
25 | 11.39 | 263 | 57, 164, 207, 263 | 79 (22) |
12 | 11.72 | 261 | 55, 164, 218, 261 | 14 (1) |
13 | 11.48 | 261 | 55, 164, 218, 261 | 84 (11) |
22 | 12.48 | 261 | 45, 105, 158, 261 | >500 |
14 | 11.49 | 259 | 43, 146, 189, 259 | 137(13) |
20 | 11.83 | 259 | 105, 146, 189, 259 | 80 (22) |
26 | 12.08 | 259 | 91, 160, 203, 259 | 58 (10) |
27 | 11.84 | 259 | 91, 160, 203, 259 | 450 (75) |
28 | 12.29 | 259 | 105, 160, 203, 259 | >1000 |
30 | 11.78 | 259 | 105, 160, 203, 259 | 4.2 (0.6) |
31 | 11.66 | 259 | 91, 105, 160, 259 | 25(6) |
2 | 12.44 | 257 | 69, 146, 189, 257 | 55 (10) |
Fentanyl (1) | 11.80 | 245 | 91, 146, 189, 245 | 32 (8) |
9 | 11.67 | 245 | 91, 160, 202, 245 | >1000 |
10 | 11.57 | 245 | 56, 91, 110, 245 | >500 |
32 | 10.85 | 245 | 57, 146, 189, 245 | 350 (7) |
33 | 13.21 | 245 | 93, 146, 189, 245 | 138(21) |
34 | 11.53 | 245 | 91, 146, 189, 245 | >500 |
11 | 11.73 | 243 | 55, 146, 200, 243 | 68 (16) |
8 | 10.72 | 231 | 91, 146, 188, 231 | >2000 |
6 | 14.24 | 95 | 95, 187, 240, 283 | 9.3 (1.9) |
19 | 11.87 | 57 | 57, 105, 146, 273 | 531 (136) |
Note. Parent compounds and their fragments are organized in order of descending base peak number. Red highlights the fluorinated analogs with the m/z 164 fragment.
Abbreviations: GC-MS, gas chromatography-mass spectrometry; RT, retention time.